Conjunctivitis other imaging findings: Difference between revisions
mNo edit summary |
m Bot: Removing from Primary care |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 16: | Line 16: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{WS}} | |||
{{WH}} | |||
[[Category:Ophthalmology]] | [[Category:Ophthalmology]] | ||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:FinalQCRequired]] | [[Category:FinalQCRequired]] | ||
[[Category:Emergency medicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
Latest revision as of 21:07, 29 July 2020
|
Conjunctivitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Conjunctivitis other imaging findings On the Web |
|
American Roentgen Ray Society Images of Conjunctivitis other imaging findings |
|
Risk calculators and risk factors for Conjunctivitis other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]
Overview
There are no other imaging findings associated with conjunctivitis. However, dynamic meibomian imaging (DMI) can be used to obtain a distinct picture of the entire everted inferior tarsal plate in a patient with keratoconjunctivitis sicca (dry eye syndrome).[1][2]
Other Imaging Findings
There are no other imaging findings associated with conjunctivitis. However, dynamic meibomian imaging (DMI) can be used in a patient with keratoconjunctivitis sicca (dry eye syndrome)[2] [3]
Kertoconjunctivitis Sicca
Dynamic Meibomian Imaging
Dynamic meibomian imaging (DMI) provides a distinct picture of the entire everted inferior tarsal plate, allowing both the clinician and the patient to assess the extent of meibomian gland dysfunction.[1][2]
References
- ↑ 1.0 1.1 Qazi Y, Aggarwal S, Hamrah P (2014). "Image-guided evaluation and monitoring of treatment response in patients with dry eye disease". Graefes Arch Clin Exp Ophthalmol. 252 (6): 857–72. doi:10.1007/s00417-014-2618-2. PMC 4038672. PMID 24696045.
- ↑ 2.0 2.1 2.2 Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK (2011). "The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD". Invest Ophthalmol Vis Sci. 52 (4): 1994–2005. doi:10.1167/iovs.10-6997e. PMC 3072161. PMID 21450917.
- ↑ Azari AA, Barney NP (2013). "Conjunctivitis: a systematic review of diagnosis and treatment". JAMA. 310 (16): 1721–9. doi:10.1001/jama.2013.280318. PMC 4049531. PMID 24150468.